Table 2

Domain ratings by patients and physicians and corresponding agreement categories in the first survey

RatingsPatients, N=50Physicians, N=75Category*
≤34–7≥8≤34–7≥8
Domains and corresponding group % for each category of ratings
Anxiety304030414117C
Cognitive function302842414712C
Coping164244283636C
Daily activities including housework10187213564A
Dactylitis18226031384A
Depressive mood163844175132C
Discomfort124048165232C
Disease activity4326411683A
Embarrassment304228244531C
Emotional support223048335215B
Emotional well-being103060244828B
Employment/work4207632176A
Enthesitis8266601684A
Family roles123256255321B
Fatigue0227843363A
Financial impact203248234335C
Frustration183646334521C
Global health8246852471A
Independence81082204237B
Intimacy and sexual relations243442244729C
Leisure activities23860116128B
Medication side effects42670112465A
Nail psoriasis22344482567B
Pain4207611188A
Participation in social activities63856125236B
Physical function4247201783A
Psoriasis symptoms10325811781A
Self-management43858175231B
Self-worth224038324028C
Sleep quality82666124939B
Social support164836315712C
Spine symptoms14226412177A
Stiffness2326613663A
Stress143650325216B
Structural joint damage8246812177A
Swelling14226441383A
Systemic inflammation22344482369B
Treatment burden64846195527C
Unpredictability of disease activity103654314425B
  • Light grey cells were rated by >50% of participants. Darker grey cells with bolded font were rated as important by ≥70% of participants.

  • *Categories were defined as (A) important for both groups (>50% in each group voted the domain as ≥8); (B) important for one group but not for the other group (>50% voted the domain as ≥8 in one group and >50% voted the domain as <8 in the other); (C) less important for both groups (>50% in both groups voted the domain as <8).